Loading market data...
Latest Top News
Mangalam Drugs Scores Major ₹15 Crore Repeat Export Order for Anti-Malarial API
Mangalam Drugs and Organics Limited secured a significant repeat export order worth approximately ₹15 crore from a reputed international client for its anti-malarial API. This underlines the company’s global reputation in pharma exports and its strategic push to advance India’s API market leadership.
Stay Ahead – Explore Now! Silicon Valley Warns Of 'Superstupidity' As AI Reliance Grows






